Last updated on June 2019
Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)
Brief description of study
This study will determine the dose-response relationship of VAY736 for key efficacy and safety parameters
Clinical Study Identifier: NCT02962895
Start Over
Connect »
